BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4136824)

  • 1. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
    Glovsky MM; Cory M; Alenty A
    Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
    Hauptmann J; Markwardt F
    Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunobiology of complement.
    Burkholder PM; Littleton CE
    Pathobiol Annu; 1971; 1():215-39. PubMed ID: 4129958
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of the first component of human complement by m-(o-(2-chloro-5-fluorosulfonylphenylureido)-phenoxybutoxy)benzamidine.
    Bing DH; Mernitz JL; Spurlock SE
    Biochemistry; 1972 Nov; 11(23):4263-8. PubMed ID: 4673057
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement: optimal reaction conditions for guinea pig C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):189-99. PubMed ID: 4197333
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride.
    Baker BR; Cory M
    J Med Chem; 1971 Sep; 14(9):805-8. PubMed ID: 5140007
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the mechanism of binding of chemically modified cytophilic antibodies to macrophages.
    Thrasher SG; Cohen S
    J Immunol; 1971 Sep; 107(3):672-7. PubMed ID: 5572090
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies.
    Frank MM; Gaither T
    Immunology; 1970 Dec; 19(6):967-74. PubMed ID: 5487543
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A; Boumsell L; Borsos T; Good RA; Day NK
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium azide inhibition of complement-mediated functions.
    Shaw DR; Shaw MW; Hickman SE; Lamon EW; Griffin FM
    Immunology; 1980 Jan; 39(1):53-6. PubMed ID: 7380463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the inhibition of C56 initiated lysis (reactive lysis). I. Description of the phenomenon and methods of assay.
    McLeod B; Baker P; Gewurz H
    Immunology; 1974 Jun; 26(6):1145-57. PubMed ID: 4137213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. XIV. Inhibition of guinea pig complement by meta-substituted benzamidines.
    Baker BR; Cory M
    J Med Chem; 1969 Nov; 12(6):1049-52. PubMed ID: 5389146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical importance of the complement system].
    Spath P; Huber H
    Wien Klin Wochenschr; 1973 Jun; 85(25):445-50. PubMed ID: 4123223
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A; Boumsell L; Borsos
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fumaropimaric acid in guinea pig complement dependent and non-complement dependent biologic reactions. I. Inhibition of Forssman, reversed passive arthus, and PCA reactions by fumaropimaric acid.
    Glovsky MM; Ward PA; Becker EL; Halbrook NJ
    J Immunol; 1969 Jan; 102(1):1-14. PubMed ID: 4237108
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
    Hoffmann A; Markwardt F
    Pharmazie; 1989 Feb; 44(2):141-4. PubMed ID: 2748697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automation of immune hemolytic and complement reactions by AutoAnalyzer. II.
    Vargues R; Henley W
    Mt Sinai J Med; 1974; 41(3):453-79. PubMed ID: 4134099
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of immune haemolysis by bovine serum albumin.
    Friedman HP; Williams MO; Muraski F
    Cytobios; 1971 Dec; 4(15):245-53. PubMed ID: 5151651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.